New PET scan outperforms standard tests for rare tumors
NCT ID NCT06240741
First seen Feb 03, 2026 · Last updated May 23, 2026 · Updated 17 times
Summary
This study tested a special PET/CT scan using a radioactive tracer called [68Ga]Ga-DOTA-TATE to see if it could better detect neuroendocrine tumors compared to standard imaging. 71 adults in Japan, including patients with known or suspected tumors and healthy volunteers, took part. The results will help determine if this scan should be used more widely for diagnosis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE NEOPLASMS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Novartis Investigative Site
Kashiwa, Chiba, 277 8577, Japan
-
Novartis Investigative Site
Sapporo, Hokkaido, 060 8648, Japan
-
Novartis Investigative Site
Kanazawa, Ishikawa-ken, 920 8641, Japan
-
Novartis Investigative Site
Yokohama, Kanagawa-ku, 236-0004, Japan
-
Novartis Investigative Site
Chuo Ku, Tokyo, 1040045, Japan
-
Novartis Investigative Site
Fukuoka, 8128582, Japan
-
Novartis Investigative Site
Fukuoka, 813-0017, Japan
-
Novartis Investigative Site
Kyoto, 6068507, Japan
Conditions
Explore the condition pages connected to this study.